Chi-Ming Liu

1.2k total citations
39 papers, 969 citations indexed

About

Chi-Ming Liu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chi-Ming Liu has authored 39 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chi-Ming Liu's work include Retinal Diseases and Treatments (5 papers), Traditional and Medicinal Uses of Annonaceae (5 papers) and Natural product bioactivities and synthesis (3 papers). Chi-Ming Liu is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Traditional and Medicinal Uses of Annonaceae (5 papers) and Natural product bioactivities and synthesis (3 papers). Chi-Ming Liu collaborates with scholars based in Taiwan, China and United Kingdom. Chi-Ming Liu's co-authors include Chung‐Yi Chen, Chiu‐Li Kao, Yi‐Ching Lo, Huiming Wu, Yu‐Ting Tseng, Wei‐Jen Li, Ing‐Jun Chen, Jorn‐Hon Liu, Tao‐Hsin Tung and Deng‐Chyang Wu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Chi-Ming Liu

37 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi-Ming Liu Taiwan 16 368 161 112 112 92 39 969
Kalyan C. Nagulapalli Venkata United States 15 436 1.2× 136 0.8× 135 1.2× 162 1.4× 47 0.5× 18 1.5k
Tomonori Nakamura Japan 23 399 1.1× 231 1.4× 190 1.7× 215 1.9× 62 0.7× 114 1.6k
Gomaa Mostafa‐Hedeab Egypt 22 431 1.2× 133 0.8× 119 1.1× 138 1.2× 35 0.4× 68 1.3k
Biyu Hou China 18 391 1.1× 113 0.7× 142 1.3× 80 0.7× 40 0.4× 32 974
Deshi Dong China 19 518 1.4× 209 1.3× 67 0.6× 159 1.4× 34 0.4× 58 1.2k
Melita Vidaković Serbia 21 495 1.3× 77 0.5× 108 1.0× 120 1.1× 58 0.6× 81 1.2k
Luíza Antas Rabelo Brazil 20 463 1.3× 97 0.6× 126 1.1× 172 1.5× 119 1.3× 36 1.6k
Mei-Ling Tsai Taiwan 18 486 1.3× 88 0.5× 68 0.6× 98 0.9× 34 0.4× 36 1.1k
Mengnan Zeng China 18 576 1.6× 212 1.3× 101 0.9× 212 1.9× 40 0.4× 105 1.3k

Countries citing papers authored by Chi-Ming Liu

Since Specialization
Citations

This map shows the geographic impact of Chi-Ming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Ming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Ming Liu more than expected).

Fields of papers citing papers by Chi-Ming Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Ming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Ming Liu. The network helps show where Chi-Ming Liu may publish in the future.

Co-authorship network of co-authors of Chi-Ming Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Ming Liu. A scholar is included among the top collaborators of Chi-Ming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Ming Liu. Chi-Ming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Chi-Ming, et al.. (2023). Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways. Saudi Pharmaceutical Journal. 31(7). 1219–1228. 3 indexed citations
3.
Chen, Chung‐Yi, et al.. (2023). A New Homosesquiterpene from Cinnamomum reticulatum. Chemistry of Natural Compounds. 59(2). 282–284. 4 indexed citations
4.
Liu, Chi-Ming, et al.. (2022). Anticancer and Overcoming Multidrug Resistance Activities of Potential Phytochemicals. 4(1). 1 indexed citations
5.
6.
Chen, Chung‐Yi, Chiu‐Li Kao, & Chi-Ming Liu. (2018). The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway. International Journal of Molecular Sciences. 19(9). 2729–2729. 270 indexed citations
7.
Hsu, Hung‐Te, et al.. (2018). Resveratrol prevents nanoparticles-induced inflammation and oxidative stress via downregulation of PKC-α and NADPH oxidase in lung epithelial A549 cells. BMC Complementary and Alternative Medicine. 18(1). 211–211. 40 indexed citations
8.
Liu, Chi-Ming, Chiu‐Li Kao, Yu‐Ting Tseng, Yi‐Ching Lo, & Chung‐Yi Chen. (2017). Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell. Molecules. 22(9). 1477–1477. 65 indexed citations
9.
Liu, Chi-Ming, et al.. (2017). Evaluation and analysis of phytochemical antioxidant capacity. Biomedical Research-tokyo. 28(14). 6431–6434. 9 indexed citations
10.
Liu, Chi-Ming, et al.. (2015). Biofunctional Constituents from Michelia compressa var. lanyuensis with Anti-Melanogenic Properties. Molecules. 20(7). 12166–12174. 10 indexed citations
11.
Kang, Yafei, Chi-Ming Liu, Chiu‐Li Kao, & Chung‐Yi Chen. (2014). Antioxidant and Anticancer Constituents from the Leaves of Liriodendron tulipifera. Molecules. 19(4). 4234–4245. 39 indexed citations
12.
Liu, Chi-Ming, et al.. (2014). Antioxidant and Anticancer Aporphine Alkaloids from the Leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena. Molecules. 19(11). 17829–17838. 119 indexed citations
13.
Lee, Chien‐Hsing, Chi-Ming Liu, Yun Li, et al.. (2014). Review on Pharmacological Activities of Cinnamomum reticulatum. 27–29. 1 indexed citations
14.
Liu, Chi-Ming, Chiu‐Li Kao, Yafei Kang, et al.. (2014). Pharmacological studies of isoobtusilactone A from Cinnamomum kotoense with anticancer potential. Journal of natural product and plant resources. 4(3). 26–29. 1 indexed citations
15.
Chen, Yen‐Ling, Yi‐Ting Tsai, Chung‐Yi Lee, et al.. (2014). Urotensin II Inhibits Doxorubicin-Induced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway. PLoS ONE. 9(9). e106812–e106812. 15 indexed citations
16.
Wu, Huiming, et al.. (2013). The Pharmacological Activities of (−)-Anonaine. Molecules. 18(7). 8257–8263. 33 indexed citations
17.
Liu, Jorn‐Hon, Mimi Chen, Li-Kang Ho, et al.. (2010). Therapeutic Effects and Mechanisms of Action of Mannitol During H 2 O 2 -Induced Oxidative Stress in Human Retinal Pigment Epithelium Cells. Journal of Ocular Pharmacology and Therapeutics. 26(3). 249–257. 25 indexed citations
18.
19.
Liu, Chi-Ming, et al.. (2009). KMUP-1 attenuates serum deprivation-induced neurotoxicity in SH-SY5Y cells: Roles of PKG, PI3K/Akt and Bcl-2/Bax pathways. Toxicology. 268(1-2). 46–54. 30 indexed citations
20.
Shih, Yu‐Tzu, Deng‐Chyang Wu, Chi-Ming Liu, et al.. (2007). San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells. Journal of Ethnopharmacology. 112(3). 537–544. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kalyan C. Nagulapalli Venkata Breakdown of academic impact, for papers by Tomonori Nakamura Breakdown of academic impact, for papers by Gomaa Mostafa‐Hedeab Breakdown of academic impact, for papers by Biyu Hou Breakdown of academic impact, for papers by Deshi Dong Breakdown of academic impact, for papers by Melita Vidaković Breakdown of academic impact, for papers by Luíza Antas Rabelo Breakdown of academic impact, for papers by Mei-Ling Tsai Breakdown of academic impact, for papers by Mengnan Zeng
Rankless by CCL
2026